Medicare Enrolled

Dr. Lin Soe, MBBS, MPH, TM

Hematology & Oncology · San Luis Obispo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
715 TANK FARM RD STE C, San Luis Obispo, CA 93401
8055435577
In practice since 2006 (19 years)
NPI: 1467524900 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Soe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Soe

Dr. Lin Soe is a hematology & oncology specialist in San Luis Obispo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Soe performed 1,664 Medicare services across 823 unique beneficiaries.

Between the years covered by Open Payments, Dr. Soe received a total of $11,591 from 82 pharmaceutical and/or device companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Soe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in CA $11,591 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,664
Medicare services
Top 42% in CA for hematology & oncology
823
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,086 $97 $285
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
279 $138 $310
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
127 $70 $195
New patient office visit, complex (60-74 min) 84 $171 $436
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
70 $118 $418
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
18 $98 $236
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,591
Total received (2018-2024)
Avg $1,656/year across 7 years
Top 30% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
611
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,144 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$447 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,754
2023
$2,775
2022
$2,185
2021
$155
2020
$391
2019
$1,141
2018
$1,190

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$329
Daiichi Sankyo Inc.
$265
Exelixis Inc.
$252
Genentech USA, Inc.
$214
Novartis Pharmaceuticals Corporation
$207
PharmaEssentia USA Corporation
$183
Merck Sharp & Dohme LLC
$180
ABBVIE INC.
$167
GlaxoSmithKline, LLC.
$160
Astellas Pharma US Inc
$139
E.R. Squibb & Sons, L.L.C.
$138
PFIZER INC.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$116
Lilly USA, LLC
$115
Eisai Inc.
$112
AstraZeneca Pharmaceuticals LP
$109
Blueprint Medicines Corporation
$108
Celgene Corporation
$104
ADC Therapeutics America, Inc.
$64
Karyopharm Therapeutics Inc.
$53
ARRAY BIOPHARMA INC
$51
Gilead Sciences, Inc.
$50
SOBI, INC
$48
Apellis Pharmaceuticals, Inc.
$42
Rigel Pharmaceuticals, Inc.
$40
Stemline Therapeutics Inc.
$31
Mirati Therapeutics, Inc.
$31
Alnylam Pharmaceuticals Inc.
$30
Medtronic, Inc.
$29
Pharmacosmos Therapeutics Inc.
$29
Ipsen Biopharmaceuticals, Inc
$24
SERVIER PHARMACEUTICALS LLC
$22
JAZZ PHARMACEUTICALS INC.
$22
SpringWorks Therapeutics, Inc.
$22
Genmab U.S., Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
EMD Serono, Inc.
$18
Agios Pharmaceuticals, Inc.
$15
GENZYME CORPORATION
$14
Incyte Corporation
$14
Top 3 companies account for 22.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,028
Janssen Biotech, Inc.
$730
PFIZER INC.
$652
Novartis Pharmaceuticals Corporation
$623
AstraZeneca Pharmaceuticals LP
$576
Genentech USA, Inc.
$553
Amgen Inc.
$428
Astellas Pharma US Inc
$417
Merck Sharp & Dohme LLC
$398
Celgene Corporation
$388
Daiichi Sankyo Inc.
$370
Exelixis Inc.
$317
Seagen Inc.
$297
GlaxoSmithKline, LLC.
$295
Takeda Pharmaceuticals U.S.A., Inc.
$259
Merck Sharp & Dohme Corporation
$229
Seattle Genetics, Inc.
$223
Blueprint Medicines Corporation
$213
PharmaEssentia USA Corporation
$208
Eisai Inc.
$200
Lilly USA, LLC
$172
ABBVIE INC.
$167
GENZYME CORPORATION
$149
JAZZ PHARMACEUTICALS INC.
$115
SOBI, INC
$111
Pharmacyclics LLC, An AbbVie Company
$103
EISAI INC.
$99
ADC Therapeutics America, Inc.
$98
Ipsen Biopharmaceuticals, Inc
$93
Alexion Pharmaceuticals, Inc.
$90
Gilead Sciences, Inc.
$88
Rigel Pharmaceuticals, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$87
Incyte Corporation
$86
Janssen Scientific Affairs, LLC
$83
Bayer Healthcare Pharmaceuticals Inc.
$83
ARRAY BIOPHARMA INC
$81
Apellis Pharmaceuticals, Inc.
$76
Karyopharm Therapeutics Inc.
$75
Mirati Therapeutics, Inc.
$67
Pharmacyclics LLC, an AbbVie Company
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Janssen Products, LP
$60
EMD Serono, Inc.
$60
Puma Biotechnology, Inc.
$50
SANOFI-AVENTIS U.S. LLC
$50
Stemline Therapeutics Inc.
$46
Secura Bio, Inc.
$42
TOLMAR Pharmaceuticals, Inc.
$40
Clovis Oncology, Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$34
ImmunoGen, Inc.
$32
AVEO Pharmaceuticals, Inc.
$31
Alnylam Pharmaceuticals Inc.
$30
Medtronic, Inc.
$29
Pharmacosmos Therapeutics Inc.
$29
PUMA BIOTECHNOLOGY, INC.
$29
Acrotech Biopharma LLC
$26
Sobi, Inc
$25
TESARO, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$22
SpringWorks Therapeutics, Inc.
$22
Genmab U.S., Inc.
$22
Deciphera Pharmaceuticals Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$19
AbbVie Inc.
$19
TAIHO ONCOLOGY, INC.
$19
AMAG Pharmaceuticals, Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
Sirtex Medical Inc
$19
CTI BioPharma Corp.
$19
Spectrum Pharmaceuticals Inc.
$17
MorphoSys, US Inc.
$16
Cumberland Pharmaceuticals, Inc.
$16
G1 Therapeutics, Inc.
$15
Agios Pharmaceuticals, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Organon LLC
$14
Roche Diagnostics Corporation
$14
Taiho Oncology, Inc.
$13
Epizyme, Inc.,
$12
MEDIVATION FIELD SOLUTIONS LLC
$8
Top 3 companies account for 20.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Aranesp · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · COSELA · Cabometyx · Columvi · DARZALEX · DAURISMO · DIS Navify Software · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Folotyn · GAUCHER-DISEASE · GAVRETO · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONTRUZANT · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNCHROMEDII · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Vanflyta · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in San Luis Obispo?
Compare hematology & oncology specialists in the San Luis Obispo area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
9
Per 100K population
3.2
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Soe is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Soe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Soe performed 1,086 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soe receive payments from pharmaceutical companies?
Yes. Dr. Soe received a total of $11,591 from 82 companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soe's costs compare to other hematology & oncology specialists in San Luis Obispo?
Dr. Soe's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →